Latebreakers: Once daily PAH drug OK'd

The new approval is in line with recommendations that suggest booster vaccination for older adults and patients aged 12 to 64 with at least 1 or more underlying risk factors.

Don Arthur, RPh, discusses what lays ahead in independent pharmacy, from clinical care to success stories.

The replacement therapy is indicated for patients 5 years and older, marking the first approval for an oral solution form of hydrocortisone.

Learn more about the ins and outs of pharmacy ownership from the experts at First Financial Bank.

This designation follows Hadlima’s low-concentration prefilled syringes and single-dose vials, which were designated in June 2024.

Ustekinumab is a medication used to treat and manage inflammatory conditions, including psoriasis, psoriatic arthritis, and inflammatory bowel disease.